Lenalidomide G.L.

Medicinal product

(Invented) name

Lenalidomide G.L.

Active substance (s)

Lenalidomidas

Strength

25 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AX04, Lenalidomide

Marketing authorisation holder

G.L. Pharma GmbH, Austrija

Date of authorisation

2020-09-30

Date of renewal

2025-10-31

Documents

Lenalidomide G.L_nestumo pranesimo forma.pdf

4614-17_pakuotes lapelis_2025-10-31.docx

Lenalidomide G.L_paciento kortele.pdf

Lenalidomide G.L mokomoji medziaga sveikatos prieziuros specialistams.pdf

Lenalidomide G.L_paciento brosiura.pdf

4614-17_Lenalidomide G_perr2025-10-31.docx

Lenalidomide G.L_sveikatos prieziuros specialisto kontrolinis sarasas.pdf

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

IS/H/0388/007/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Kapsulėje yra:	1 vnt.
Lenalidomidas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
105084	91187	1091187	lizdinė plokštelė	N7		Receptinis	LT/1/20/4617/001	Netiekiama	-	-	No	-	-
105085	91188	1091188	lizdinė plokštelė	N21		Receptinis	LT/1/20/4617/002	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-10-31	Perregistruotas
2020-09-30	Registruotas